Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
LIGAND PHARMACEUTICALS INC market cap for the quarter ending 2026-08-04 was $5.99B, a 125.86% increase year-over-year.
LIGAND PHARMACEUTICALS INC market cap for the quarter ending 2026-06-30 was $6.29B, a 184.91% increase year-over-year.
LIGAND PHARMACEUTICALS INC market cap for the quarter ending 2026-05-05 was $4.66B, a 133.60% increase year-over-year.
LIGAND PHARMACEUTICALS INC market cap for the quarter ending 2026-03-31 was $4B, a 97.33% increase year-over-year.
LIGAND PHARMACEUTICALS INC market cap for fiscal 2026 was $5.99B.
LIGAND PHARMACEUTICALS INC market cap for fiscal 2025 was $3.74B, a 82.55% increase from fiscal 2024.
LIGAND PHARMACEUTICALS INC market cap for fiscal 2024 was $2.05B, a 63.27% increase from fiscal 2023.
LIGAND PHARMACEUTICALS INC market cap for fiscal 2023 was $1.25B, a 10.73% increase from fiscal 2022.